| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $724.6M | +27.3% | +34.9% |
| R&D Expense | $9.3M | +14.9% | +13.3% |
| SG&A Expense | $65.5M | -8.4% | +8.2% |
| Operating Income | $3.7M | +103.3% | +102.9% |
| Pre-tax Income | -$280.0M | +25.1% | +34.3% |
| Income Tax | -$2.2M | +97.7% | +84.3% |
| Net Income | $16.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $248.3M | +33.1% | +36.0% |
| Inventory | $570.0M | +16.1% | +66.5% |
| Current Assets | $2.07B | +15.9% | +29.2% |
| Total Assets | $22.23B | +4.7% | +0.5% |
| Current Liabilities | $1.42B | +12.0% | +30.2% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$518.4M | — | — |
| Investing Cash Flow | -$2.09B | — | — |
| Financing Cash Flow | $2.82B | — | — |
| -94.1% |
| +119.8% |
| EPS (Basic) | $0.07 | -94.3% | +118.9% |
| EPS (Diluted) | $0.06 | -94.4% | +116.2% |
| $14.63B |
| +4.2% |
| +17.5% |
| Total Liabilities | $17.58B | +4.7% | +16.7% |
| Stockholders' Equity | $2.98B | +2.0% | -43.5% |